The psychedelic renaissance: the next trip for psychiatry?
Kelly, J. R., Baker, A., Babiker, M., Burke, L., Brennan, C., & O’Keane, V. | Irish journal of psychological medicine | 23 September 2019
Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers
Hutten, N. R., Mason, N. L., Dolder, P. C., & Kuypers, K. P. | Frontiers in psychiatry | 13 September 2019
The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression
O’Brien, B., Lijffijt, M., Wells, A., Swann, A. C., & Mathew, S. J. | Pharmaceuticals | 11 September 2019
Exploring ayahuasca‐assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada
Argento, E., Capler, R., Thomas, G., Lucas, P., & Tupper, K. W. | Drug and alcohol review | 5 September 2019
Hallucinogens and Their Therapeutic Use: A Literature Review
BEGOLA, M. J., & SCHILLERSTROM, J. E. | Journal of Psychiatric Practice | September 2019
Psychedelic drugs-a new era in psychiatry?
Garcia-Romeu, A., & Richards, W. A. | International Review of Psychiatry | September 2019
Repeated ketamine injections in synergy with antidepressants for treating refractory depression: A case showing 6-month improvement.
Wang, M., Xiong, Z., Su, B., Wang, L., Li, Z., Yang, Y., & Fang, J. | Journal of clinical pharmacy and therapeutics | 30 August 2019
Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism.
Williams, N. R., Heifets, B. D., Bentzley, B. S., Blasey, C., Sudheimer, K. D., Hawkins, J., ... & Schatzberg, A. F. | Molecular psychiatry | 29 August 2019
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Sartori, S. B., & Singewald, N. | Pharmacology & therapeutics | 27 August 2019
Ketamine and depression: a narrative review.
Corriger, A., & Pickering, G. | Drug design, development and therapy | 27 August 2019